Silverarc Capital Management’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,000,000
Closed -$7.2M 96
2023
Q1
$7.2M Sell
1,000,000
-707,370
-41% -$5.49M 2.97% 9
2022
Q4
$14M Buy
1,707,370
+51,595
+3% +$481K 4.02% 3
2022
Q3
$17.5M Buy
1,655,775
+92,818
+6% +$986K 5.91% 1
2022
Q2
$14.4M Buy
1,562,957
+327,173
+26% +$2.68M 4.45% 4
2022
Q1
$177K Buy
1,235,784
+135,784
+12% +$875K 0.07% 64
2021
Q4
$8.86M Buy
1,100,000
+735,000
+201% +$4.88M 3.59% 8
2021
Q3
$2.24M Buy
365,000
+155,067
+74% +$588K 1.27% 25
2021
Q2
$653K Buy
+209,933
New +$802K 0.29% 73

Other funds holding BLU

Silverarc Capital Management's BLU Position: Q2 2023 in Review

Silverarc Capital Management sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 1,000,000 shares — an estimated $7.2M sold.

Silverarc Capital Management first reported a position in BLU in Q2 2021 and held it in 8 quarters. The position peaked at $17.5M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Silverarc Capital Management reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Silverarc Capital Management sold 1,000,000 BELLUS Health Inc. shares in Q2 2023, an estimated $7.2M.
  • Silverarc Capital Management first reported a position in BELLUS Health Inc. in Q2 2021 and held it in 8 quarters.
  • Silverarc Capital Management's BELLUS Health Inc. position peaked at $17.5M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Silverarc Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.